Innate Pharma Stock
Innate Pharma Stock
The price for the Innate Pharma stock decreased slightly today. Compared to yesterday there is a change of -€0.004 (-0.320%).
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | -0.320% | -1.906% | -9.350% | -28.602% | -12.549% | -54.303% | -66.006% |
| Nanobiotix | -0.370% | -0.351% | 58.305% | 870.608% | 48.691% | 786.115% | 106.696% |
| Poxel S.A. | -3.700% | 3.347% | -22.205% | 18.750% | 3.347% | -68.374% | -96.280% |
| Adocia | -2.570% | -6.491% | -2.104% | 30.388% | -8.333% | 75.362% | -40.570% |
